The Oncology Institute
TOI
21 hedge funds and large institutions have $49.3M invested in The Oncology Institute in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
21.97% more ownership
Funds ownership: 0% → 21.97% (+22%)
Top Buyers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$13.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.93M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
+$4.97M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
+$2.49M |
| 5 |
MCM
Moore Capital Management
New York
|
+$2.49M |
Top Sellers
TOI Hedge Fund Activity: Q2 2020 in Review
21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q2 2020, worth a combined $49.3M.
Buyers outnumbered sellers: 21 funds opened new TOI positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $13.7M.
- 21 institutional investors held The Oncology Institute (TOI) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $49.3M of The Oncology Institute stock for Q2 2020.
- 21 funds opened new The Oncology Institute positions in Q2 2020 and 0 closed out, a net change of +21 holders.
- The largest The Oncology Institute buyer in Q2 2020 was UBS O'Connor, an estimated $13.7M added.
Based on aggregated 13F filings for Q2 2020.